Skip to main content

6-K

Ambev S.A. (ABEV)

6-K 2020-01-08 For: 2020-03-31
View Original
Added on April 12, 2026

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

For the month of January, 2020

Commission File Number 1565025

AMBEV S.A.

(Exact name of registrant as specified in its charter)

AMBEV S.A.

(Translation of Registrant's name into English)

Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor 04530-000 São Paulo, SPFederative Republic of Brazil

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ___X___ Form 40-F _______

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes _______ No ___X____

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

In December 2019:

(  ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002.^(1)^

( X ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

Company Name: Ambev S.A.
Name: Ambev Luxembourg S.À.R.L. CPF/CNPJ:
Qualification: Position – Total Return Swap
Initial Balance
Securities / Derivatives Securities Characteristics ^(2)^ Quantity
Derivatives Swap referenced in Shares 30,039,800
Derivatives Swap referenced in ADR 26,974,653
Transac tions in the month
Securities / Derivatives Securities Characteristics ^(2)^ Intermediary Operation Day Quantity Price Volume ^(3)^
Final Balance
Securities / Derivatives Securities Characteristics ^(2)^ Quantity
Derivatives Swap referenced in Shares 30,039,800
Derivatives Swap referenced in ADR 26,974,653

(1)  When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.

(2)   Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(3)   Quantity multiplied by price.

(*) In accordance with the Circular Letter/CVM/SEP/Nº07/2017, date information of the total return swap conclusion and not the date of the financial settlement of the transaction.

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

In December 2019:

( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002.^(1)^

(   ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

Company Name: Ambev S.A.
Name: Ambev S.A.
Qualification: Outstanding  Shares in Treasury
Initial Balance
Securities / Derivatives Securities Characteristics ^(2)^ Quantity
Shares Common 3,221,390
Transac tions in the month
Securities / Derivatives Securities Characteristics ^(2)^ Intermediary Operation Day Quantity Price Volume ^(3)^
Shares Common Direct with the Company Conversion into ADR 16 7,002 R 0.00 R$ 0.00
Shares Common Direct with the Company Conversion into ADR 20 3,122 R 0.00 R$ 0.00
Shares Common Direct with the Company Conversion into ADR 20 5,409 R 0.00 R$ 0.00
Shares Common Direct with the Company Conversion into ADR 23 97,667 R 0.00 R$ 0.00
Shares Common Direct with the Company Conversion into ADR 27 8,027 R 0.00 R$ 0.00
Total Conversion into ADR (Sell) 121,227 R$ 0.00
Shares Common Direct with the Company Diferred Shares 02 8,055 R 0.00 R$ 0.00
Shares Common Direct with the Company Exerc Options 04 25,385 R 11.9720 R$ 303,909.22
Shares Common Direct with the Company Exerc Options 09 25,385 R 11.9720 R$ 303,909.22
Shares Common Direct with the Company Exerc Options 13 46,000 R 6.9588 R$ 320,104.80
Shares Common Direct with the Company Exerc Options 13 45,175 R 9.3596 R$ 422,819.93
Shares Common Direct with the Company Exerc Options 13 25,385 R 11.9720 R$ 303,909.22
Shares Common Direct with the Company Exerc Options 13 19,415 R 17.1980 R$ 333,899.17
Shares Common Direct with the Company Exerc Options 13 34,225 R 17.6820 R$ 605,166.45
Shares Common Direct with the Company Exerc Options 16 29,125 R 17.1980 R$ 500,891.75
Shares Common Direct with the Company Exerc Options 16 16,126 R 17.5600 R$ 283,172.56
Shares Common Direct with the Company Exerc Options 18 30,125 R 9.3596 R$ 281,957.95
Shares Common Direct with the Company Exerc Options 18 25,385 R 11.9720 R$ 303,909.22
Shares Common Direct with the Company Exerc Options 18 38,830 R 17.1980 R$ 667,798.34

All values are in US Dollars.

Shares Common Direct with the Company Exerc Options 19 40,475 R$ 6.9588 R$ 281,657.43
Shares Common Direct with the Company Diferred Shares 19 4,033 R$ 0.00 R$ 0.00
Shares Common Direct with the Company Exerc Options 23 23,300 R$ 17.1980 R$ 400,713.40
Shares Common Direct with the Company Exerc Options 23 29,028 R$ 17.5600 R$ 509,731.68
Shares Common Direct with the Company Exerc Options 23 32,177 R$ 16.8500 R$ 542,182.45
Total Sell 529,881 R$ 6,932,077.91
Shares Common Direct with the Company Plan of Shares Acquisition 06 6,117 R$ 18.45 R$ 112,858.65
Shares Common Direct with the Company Plan of Shares Acquisition 13 104,467 R$ 19.01 R$ 1,985,917.67
Shares Common Direct with the Company Plan of Shares Acquisition 16 41,094 R$ 19.08 R$ 784,073.52
Shares Common Direct with the Company Plan of Shares Acquisition 18 80,570 R$ 19.09 R$ 1,538,081.30
Shares Common Direct with the Company Plan of Shares Acquisition 20 8,961 R$ 18.91 R$ 169,452.51
Shares Common Direct with the Company Plan of Shares Acquisition 23 76,616 R$ 18.96 R$ 1,452,639.36
Shares Common Direct with the Company Plan of Shares Acquisition 26 733,800 R$ 19.22 R$ 14,103,636.00
Total Buy 1,051,625 R$ 20,146,659.01
ADR Common Direct with the Company Conversion into ADR 16 7,002 R$ 0.00 R$ 0.00
ADR Common Direct with the Company Conversion into ADR 20 3,122 R$ 0.00 R$ 0.00
ADR Common Direct with the Company Conversion into ADR 20 5,409 R$ 0.00 R$ 0.00
ADR Common Direct with the Company Conversion into ADR 23 97,667 R$ 0.00 R$ 0.00
ADR Common Direct with the Company Conversion into ADR 27 8,027 R$ 0.00 R$ 0.00
Conversion into ADR (Buy) 121,227 R$ 0.00
ADR Common Direct with the Company Plan of Shares Acquisition 16 32,473 R$ 19.0538472 R$ 618,735.58
ADR Common Direct with the Company Plan of Shares Acquisition 20 24,491 R$ 19.0570511 R$ 466,726.24
ADR Common Direct with the Company Plan of Shares Acquisition 27 5,298 R$ 19.0984560 R$ 101,183.62
Total Buy 62,262 R$ 1,186,645.44
ADR Common Direct with the Company Exerc Options 16 39,475 R$ 15.6741122 R$ 618,735.58
ADR Common Direct with the Company Exerc Options 20 29,900 R$ 15.6095732 R$ 466,726.24
ADR Common Direct with the Company Diferred ADR 20 3,122 R$ 0.00 R$ 0.00
ADR Common Direct with the Company Phantom ADR 23 97,667 R$ 15.9180860 R$ 1,554,671.70
ADR Common Direct with the Company Exerc Options 27 13,325 R$ 7.5935174 R$ 101,183.62
Total Sell 183,489 R$ 2,741,317.14
Final Balance
Securities / Derivatives Securities Characteristics ^(2)^ Quantity
Shares Common 3,621,907

(1) **** When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.

(2) **** Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(3) **** Quantity multiplied by price .

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: January 8, 2020

AMBEV S.A.
By: /s/ Fernando Mommensohn Tennenbaum
Fernando Mommensohn Tennenbaum<br><br><br> <br>Chief Financial and Investor Relations Officer